Astellas And AstraZeneca To Launch Symbicort Turbuhaler
This article was originally published in PharmAsia News
Executive Summary
Astellas and AstraZeneca announced they will launch Symbicort Turbuhaler (budesonide/formoterol) for adult bronchial asthma patients in Japan next January